uniQure NV
uniQure NV (QURE) Straddle
QURE straddle scan found 200 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 67.6%.
Read more
Trading a QURE straddle lets you take a pure volatility position on uniQure NV without committing to a direction. uniQure NV's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate QURE straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on QURE profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when uniQure NV stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the QURE straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis.
uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the QURE straddle is the cleanest expression of that view. Our scanner prices every QURE straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a QURE straddle into a catalyst or short a QURE straddle to harvest decay, the options straddle setups that matter are all in one place.
| Jan 21, 2028 | 100.00 | $70.90 | 485 | 51% | 67.6% | $170.90 | $29.10 | 1 |
| Jan 21, 2028 | 90.00 | $62.55 | 485 | 51% | 66.8% | $152.55 | $27.45 | 5 |
| Jan 21, 2028 | 95.00 | $67.25 | 485 | 51% | 66.7% | $162.25 | $27.75 | 0 |
| Jan 21, 2028 | 85.00 | $59.30 | 485 | 51% | 65.4% | $144.30 | $25.70 | 0 |
| Jan 21, 2028 | 80.00 | $55.70 | 485 | 51% | 64.4% | $135.70 | $24.30 | 0 |
| Jan 21, 2028 | 75.00 | $52.30 | 485 | 51% | 63.0% | $127.30 | $22.70 | 6 |
| Jan 15, 2027 | 100.00 | $58.20 | 114 | 51% | 61.4% | $158.20 | $41.80 | 50 |
| Jan 15, 2027 | 95.00 | $53.50 | 114 | 51% | 61.3% | $148.50 | $41.50 | 0 |
| Jan 21, 2028 | 70.00 | $49.10 | 485 | 51% | 61.2% | $119.10 | $20.90 | 5 |
| Jan 15, 2027 | 90.00 | $49.10 | 114 | 51% | 60.7% | $139.10 | $40.90 | 0 |
As of September 25, 2026
Find the right straddle before volatility moves
Track QURE straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→